William G. Wright

Array ( [id] => 7712190 [patent_doc_number] => 20120004317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Tapentadol for use in the treatment of irritable bowel syndrome' [patent_app_type] => utility [patent_app_number] => 13/172103 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5314 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13172103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670136 [patent_doc_number] => 20110319405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors' [patent_app_type] => utility [patent_app_number] => 13/171441 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22188 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13171441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663775 [patent_doc_number] => 20110313044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Polymorphs of Suberoylanilide Hydroxamic Acid' [patent_app_type] => utility [patent_app_number] => 13/161763 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6259 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313044.pdf [firstpage_image] =>[orig_patent_app_number] => 13161763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8830021 [patent_doc_number] => 20130131066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'TREATMENT OF TYPE 1 DIABETES' [patent_app_type] => utility [patent_app_number] => 13/703147 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5717 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916877 [patent_doc_number] => 20130178503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'METHODS OF TREATING HEMATOLOGIC MALIGNANCIES USING 6-CYCLOHEXYL-1-HYDROXY-4-METHYL-2(1H)-PYRIDONE' [patent_app_type] => utility [patent_app_number] => 13/701486 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20189 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651925 [patent_doc_number] => 20110301194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Method for Determining Treatment Efficacy' [patent_app_type] => utility [patent_app_number] => 13/150295 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21385 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301194.pdf [firstpage_image] =>[orig_patent_app_number] => 13150295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831909 [patent_doc_number] => 08940725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Purinone derivative' [patent_app_type] => utility [patent_app_number] => 13/700774 [patent_app_country] => US [patent_app_date] => 2011-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25009 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8183966 [patent_doc_number] => 20120114588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/116422 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24317 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114588.pdf [firstpage_image] =>[orig_patent_app_number] => 13116422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977383 [patent_doc_number] => 20130210813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'Male Contraceptive Compositions and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/698006 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24711 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9068126 [patent_doc_number] => 20130259882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-03 [patent_title] => 'Conjugate of Folate and Antibody Preparation Method and Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/884265 [patent_app_country] => US [patent_app_date] => 2011-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9168 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660149 [patent_doc_number] => 20130040978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/641767 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53059 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8830133 [patent_doc_number] => 20130131178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'USE OF OXALOACETATE IN THE TREATMENT OF ISCHAEMIA' [patent_app_type] => utility [patent_app_number] => 13/699590 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4249 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8822240 [patent_doc_number] => 20130123285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'Compositions and Methods for Targeting A3G:RNA Complexes' [patent_app_type] => utility [patent_app_number] => 13/697932 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18165 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9603520 [patent_doc_number] => 20140200203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'TOPICAL PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/699333 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6346 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359570 [patent_doc_number] => 20120214734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'TREATMENT OF METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/106608 [patent_app_country] => US [patent_app_date] => 2011-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8612 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13106608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9869314 [patent_doc_number] => 08957086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Compounds and methods of treating brain disorders' [patent_app_type] => utility [patent_app_number] => 13/695731 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 19438 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660138 [patent_doc_number] => 20130040967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => '4\'-DEMETHYLEPIPODOPHYLLOTOXIN DERIVATIVE, PREPARATION METHOD AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/641114 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6123 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638217 [patent_doc_number] => 20130030019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/638991 [patent_app_country] => US [patent_app_date] => 2011-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24341 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660141 [patent_doc_number] => 20130040969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'Fungicidal Mixtures Based on Azolopyrimmidinylamines' [patent_app_type] => utility [patent_app_number] => 13/641754 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48067 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660172 [patent_doc_number] => 20130041001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'VALSARTAN DERIVATIVES CARRYING NITROGEN OXIDE DONORS FOR THE TREATMENT OF VASCULAR AND METABOLIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/641747 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6742 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641747 [rel_patent_id] =>[rel_patent_doc_number] =>)